Prostate Cancer Program News


Prostate Cancer Program 2023 Pilot Research Awards

Research Pilot Funding

The UCSF Prostate Cancer Program announces a call for applications for funds for pilot projects in prostate cancer research at UCSF. All areas of prostate cancer research at UCSF, including computational, laboratory, translational, clinical, and population sciences, are eligible for awards. This is the second cycle of funding in 2023.

Award Amount                                                

  • Up to $50,000 total, direct costs only

Key Dates

  • Application deadline:  November 15, 2023
  • Award period: January 1, 2024 - December 31, 2024

Eligible Applicants  

  • UCSF Faculty, including Instructors and Adjunct Professors
  • UCSF Learners/Trainees (e.g., Students, Residents, Fellows -- clinical and research) and non-Faculty (e.g., Specialists)
  • Joint proposals by co-investigators are welcome


Priorities for Funding 

Proposals in any of the following categories are especially encouraged: 

  • Early- to Mid-Career applicants (Trainee through Associate Professor) 
  • Translational research (T1-T3) 
  • Projects whose completion within 12 months is feasible. 
  • Projects with strong potential for subsequent peer-reviewed funding

Application Materials

Program Events

Upcoming Events

Prostate Cancer Program 2023 Annual Scientific Retreat

  • Nov 3, 2023, 8am -  5pm
  • This is an internal scientific meeting for the UCSF cancer research community. More details TBA!

2024 Patient Conference on Prostate Cancer

  • Saturday, March 9, 2024 | Save the date!

Past Events

Prostate Cancer Program Research Seminar
Apr 5, 2023 | Speaker: Yulin Hswen, ScD, MPH, Assistant Professor of Epidemiology and Biostatistics, UCSF

Prostate Cancer Program Research Workshop
Feb 1, 2023 | Topic: Bench to Bedside Therapeutics in Prostate Cancer

2022 Patient Conference on Prostate Cancer
Oct 15, 2022 | For patients, families, caregivers, health care providers, and all those interested in information and tools to make informed decisions in prostate cancer.

Prostate Cancer Program Annual Scientific Retreat
Sept 23, 2022 | A hybrid (in person and virtual) retreat.

Prostate Cancer Program Research Workshop

Nov 17, 2021 | Topic: Beyond PSMA Lutetium Approval: the Unanswered Questions

HDFCCC Research Symposium: Challenges and Opportunities in Prostate Cancer Immunotherapy

June 30, 2021 | Jointly presented by the Cancer Immunology & Immunotherapy Program and the Prostate Cancer Program of the Helen Diller Family Comprehensive Cancer Center

2021 Patient Conference on Prostate Cancer

May 14, 2021 | Co-hosted by the California Prostate Cancer Coalition, this conference was designed to help patients think about their care, discuss their case with their own doctors and others, and join in effective informed decision-making.

Prostate Cancer Program Funded Research

2023 Funded Research
  • Jonathan Chou, MD, PhD
    Inhibition as a Therapeutic Strategy for CDK12-Mutated Prostate Cancer
  • Erin Van Blarigan, ScD
    Eating Better Together: Developing a Dyadic Dietary Intervention for Prostate Cancer Patients and their Partners
  • Meng Zhang, MSc, PhD
    Investigation of Microproteins as Novel Druggable Targets in Prostate Cancer
2022 Funded Research

Research Pilot Award Recipients (Round 1)

  • Ivan de Kouchkovsky, MD
    HP 13C MRI as an Early Response Biomarker to Androgen Deprivation Therapy Plus Abiraterone And Ipatasertib in Pelvic Node Positive Prostate Cancer
  • Arian Lundberg, MSc, PhD
    Investigating the Association Between Microbiota Dysbiosis and Patient’s Survival in Advanced Prostate Cancer
  • Woogwang Sim, PhD
    PTEN/TP53 Altered Prostate Cancer Has Unique Role for Tumor Associated Macrophages Upon Apalutamide Resistance

Research Pilot Award Recipients (Round 2)

  • Arpita Desai, MD
    PSMA PET as a Longitudinal Biomarker in Patients Undergoing Intensified Intermittent ADT
  • Nynikka Palmer, DrPH, MPH
    PACE Yourself: Optimizing Patient-Centered Communication for Prostate Cancer Care in the Safety-Net
  • Samuel Washington III, MD, MAS
    Understanding Association Between Social Risk and Guideline Concordant Treatment for Clinically Localized Prostate Cancer
  • Noah Younger, MD, PhD
    Characterizing cPRC1 as a Mediator of Enzalutamide Resistance in Advanced Prostate Cancer
2021 Funded Research
  • Rebecca Graff, ScD
    Metabolomic Disparities Between Black and White Men with Metastatic Prostate Cancer
  • Haolong Li, PhD
    Investigating PTGES3 as a Novel Therapeutic Target in Advanced Prostate Cancer
  • Osama Mohamad, MD, PhD
    Artificial Intelligence-Based Tools to Improve Decision Making for Patients with Prostate Cancer on Active Surveillance
  • Duygu Kuzuoglu Oztur, PhD
    Elucidating the Roles of Different 5'UTRs of AR mRNA in Prostate Cancer
  • Jingjing Li, PhD
    Single-Cell Analysis of Germline Mutations Conferring Population Disparities in Prostate Cancer
  • Li Zhang, PhD
    Quantification of Adaptive Immune Response to Pembrolizumab for mCRPC Patients
2019 Funded Research
  • Nam Woo Cho, MD, PhD
    Systematic Dissection of Anti-Tumor Immunity Against Mismatch Repair-Deficient Prostate Cancer
  • Crystal Langlais, MPH
    Development and Examination of Post-Diagnostic Lifestyle Scores for the Prevention of Prostate Cancer Progression
  • Jingjing Li, PhD
    Deep Learning to Identify the Altered Chromatin Architecture from Large-Scale Prostate Cancer Genomes
  • Ruhollah Moussavi-Baygi, PhD
    An in-silico Functional Genomics Approach for Determining Drivers of mCRPC in Individual Patients
  • David Quigley, PhD
    Etiology and Therapeutic Vulnerabilities of Hypermethylated Metastatic Prostate Tumors
2018 Funded Research
  • Rohit Bose, MD, PhD
    Key Tumor Suppressors in Prostate Cancer Lacking ETS Fusions
  • MinKyu Kim, PhD and Jonathan Chou, MD, PhD
    Mapping the Therapeutic Vulnerabilities of CDK12-Mutated Prostate Cancer
  • Renuka Sriram, PhD
    Metabolic Characterization of Prostate Cancer Bone Metastatic Phenotypes Using Hyperpolarized 13C MRI -  Improved Assessment of Therapeutic Response
2017 Funded Research
  • Mekhail Anwar, MD, PhD
    A Microfabricated Imaging Platform for Intraoperative Detection of Microscopic Nodal and Margin Involvement in Prostate Cancer
  • Robert Flavell, MD, PhD
    Boronated PSMA Neutron Capture Therapy for Treatment of Advanced Prostate Cancer
  • Luke Gilbert, PhD
    Engineering an Expanded Therapeutic Window for Imaging and Treating Metastatic Prostate Cancer
  • Hani Goodarzi, PhD
    Systematic Identification of Post-Transcriptional Regulatory Pathways that Drive Prostate Cancer
  • Jim Wells, PhD
    Characterizing and Targeting the MYC Surface-ome in Advanced Prostate Cancer


Benioff Initiative for Prostate Cancer Research

The mission of the UCSF Benioff Initiative for Prostate Cancer Research is to understand the fundamental biology underlying aggressive prostate cancer and develop strategies that will lead to a cure for metastatic disease.